Brain MR Spectroscopic Findings in 3 Consecutive Patients with COVID-19: Preliminary Observations.
Otto RapalinoAkila WeerasekeraSarah J MoumKatharina Eikermann-HaerterBrian L EdlowDavid FischerAngel Torrado-CarvajalMarco L LoggiaShibani S MukerjiPamela W SchaeferRamon Gilberto GonzálezMichael H LevEva-Maria RataiPublished in: AJNR. American journal of neuroradiology (2020)
Brain multivoxel MR spectroscopic imaging was performed in 3 consecutive patients with coronavirus disease 2019 (COVID-19). These included 1 patient with COVID-19-associated necrotizing leukoencephalopathy, another patient who had a recent pulseless electrical activity cardiac arrest with subtle white matter changes, and a patient without frank encephalopathy or a recent severe hypoxic episode. The MR spectroscopic imaging findings were compared with those of 2 patients with white matter pathology not related to Severe Acute Respiratory Syndrome coronavirus 2 infection and a healthy control subject. The NAA reduction, choline elevation, and glutamate/glutamine elevation found in the patient with COVID-19-associated necrotizing leukoencephalopathy and, to a lesser degree, the patient with COVID-19 postcardiac arrest, follow a similar pattern as seen with the patient with delayed posthypoxic leukoencephalopathy. Lactate elevation was most pronounced in the patient with COVID-19 necrotizing leukoencephalopathy.
Keyphrases
- coronavirus disease
- sars cov
- respiratory syndrome coronavirus
- white matter
- case report
- high resolution
- magnetic resonance imaging
- molecular docking
- magnetic resonance
- resting state
- cell proliferation
- functional connectivity
- computed tomography
- cell cycle
- molecular dynamics simulations
- cerebral ischemia
- drug induced